| iPSC-Derived Dopaminergic Neurons | |
|---|---|
| Lineage | Stem Cell > iPSC > Dopaminergic |
| Markers | TH, SLC6A3, LMX1A, PITX3, FOXA2, EN1 |
| Brain Regions | In Vitro (Midbrain Patterning) |
| Disease Relevance | Parkinson's Disease, Drug Development, Disease Modeling |
| Protocol | Directed Differentiation (14-21 days) |
Ipsc Derived Dopaminergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
iPSC-Derived Dopaminergic Neurons are specialized neurons generated from induced pluripotent stem cells (iPSCs) through directed differentiation protocols that recapitulate midbrain development.1 These cells express key dopaminergic markers including tyrosine hydroxylase (TH), the dopamine transporter (SLC6A3/DAT), and transcription factors LMX1A, PITX3, and FOXA2 that define the midbrain dopaminergic lineage.2
iPSC-derived dopaminergic neurons provide a physiologically relevant in vitro model for studying Parkinson's disease (PD) pathogenesis, screening potential therapeutics, and developing cell replacement therapies.3 These cells can be generated from patients with familial PD mutations (LRRK2 G2019S, SNCA multiplications, GBA) as well as sporadic cases, enabling disease modeling in a patient-specific context.4
The generation of dopaminergic neurons from iPSCs typically follows a directed differentiation approach that mimics embryonic midbrain development:
iPSC-derived dopaminergic neurons are characterized by the following marker expression profile:
| Marker | Type | Function |
|---|---|---|
| TH | Enzyme | Rate-limiting step in dopamine synthesis |
| SLC6A3 (DAT) | Transporter | Dopamine reuptake |
| DDC (AADC) | Enzyme | DOPA decarboxylase |
| LMX1A | Transcription Factor | Midbrain DA neuron specification |
| PITX3 | Transcription Factor | DA neuron survival and maintenance |
| FOXA2 | Transcription Factor | Floor plate identity |
| EN1 | Transcription Factor | Midbrain-hindbrain boundary |
iPSC-derived dopaminergic neurons from PD patients exhibit several pathological features:
These neurons serve as platforms for:
iPSC-derived dopaminergic progenitors are being developed for transplantation therapy in PD:
| Cell Source | Advantages | Limitations |
|---|---|---|
| Primary fetal tissue | Physiologically mature | Ethical concerns, limited supply |
| ESC-derived | Unlimited potential | Tumor risk, immune issues |
| iPSC-derived | Patient-specific, autologous possible | Cost, reprogramming variability |
| Direct reprogramming | Fast, no pluripotent stage | Incomplete maturation |
The study of Ipsc Derived Dopaminergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.